Press releases
EMA recommends temporary suspension of EQL Pharma drug, with reduced earnings for 2017 as a result
2017-04-03 The European Medicines Agency recommends a temporary withdrawal of a number of drugs for which bioequivalence studies has been conducted at Micro Therapeutic Research Labs, India.
Press Release 2017-04-03
-
2018-11-13Clindamycin EQL Pharma approved
Clindamycin EQL Pharma is a bactericidal agent (antibiotic). Clindamycin EQL Pharma is…
-
2018-10-29EQL Pharma publishes information memorandum
The rights issue in brief Subscription period October 30th until November 13th,…
-
2018-10-17EQL Pharma resolves on a rights issue of approximately SEK 24.9 million and announces changed date for publication of the Q2 interim report to 18th October, 2018
The rights issue in brief Pursuant to the authorization resolved by the…
-
2018-08-24Anders Månsson appointed new member of the Board of EQL Pharma AB
Anders Månsson has extensive experience from the pharmaceutical industry and has worked…
-
2018-08-22Report from the Annual General Meeting of EQL Pharma AB (publ) on August 22nd, 2018
Adoption of the balance sheet and income statement, disposition regarding the Company’s…
-
2018-06-26Acetazolamide EQL Pharma now approved for sale
Acetazolamide EQL Pharma is used as a short-term treatment for eye surgery…
-
2018-04-10Prednisolon EQL Pharma now approved for sale
Prednisolone EQL Pharma is used in the state where one needs to…
-
2018-02-27Paracetamol EQL Pharma approved
Paracetamol is a very common drug and sells in high volumes in…
-
2018-02-20Launch of Potassium chloride determined
Potassium chloride EQL Pharma is part of EQL Pharmas long-term commitment to…
-
2017-12-29EQL Pharma strengthens its organization with Axel Schörling, new Chief Operating Officer
He has a background as a management consultant at BearingPoint and most…
-
2017-11-24EQL Pharma signs agreement with leading generic company
EQL estimates that the profitability will be similar, whether EQL Pharma sells…
-
2017-07-05Positive news concerning the pharmaceutical product Eletriptan EQL Pharma
The pharmaceutical product Eletriptan EQL Pharma was approved Monday within the framework…
-
2017-07-03Zonisamid EQL Pharma launched in Denmark
Zonisamide EQL Pharma is an antiepileptic, used for the treatment of epilepsy.…
-
2017-05-17Report from the Annual General Meeting of EQL Pharma AB (publ) on May 15th, 2017
Adoption of the balance sheet and income statement, disposition regarding the Company’s…
-
2017-05-09Positive news concerning the pharmaceutical product Kaliumklorid EQL Pharma
The pharmaceutical product Kaliumklorid EQL Pharma (potassium chloride tablets) has today been…
-
2017-01-23The Nomination Committee for the Annual General Meeting in 2017
2017-01-23 In accordance with a resolution from the 2016 Annual General Meeting…
-
2016-11-16EQL Pharma strengthens its organization with Alexander Brising, New Business Development Director
EQL Pharma has recruited Alexander Brising as head of business development at…
-
2016-10-10Zonisamid EQL Pharma now approved in Denmark
The medical product Zonisamid EQL Pharma has now been approved for sale…